Pregled bibliografske jedinice broj: 1270385
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort // Eurosurveillance, 24 (2019), 48; 1900604, 12 doi:10.2807/1560-7917.es.2019.24.48.1900604 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1270385 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort
Autori
Kissling, Esther ; Pozo, Francisco ; Buda, Silke ; Vilcu, Ana-Maria ; Gherasim, Alin ; Brytting, Mia ; Domegan, Lisa ; Gómez, Verónica ; Meijer, Adam ; Lazar, Mihaela ; Vučina, Vesna Višekruna ; Dürrwald, Ralf ; van der Werf, Sylvie ; Larrauri, Amparo ; Enkirch, Theresa ; O’Donnell, Joan ; Guiomar, Raquel ; Hooiveld, Mariëtte ; Petrović, Goranka ; Stoian, Elena ; Penttinen, Pasi ; Valenciano, Marta ; I-MOVE primary care study team
Izvornik
Eurosurveillance (1560-7917) 24
(2019), 48;
1900604, 12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
influenza vaccination, test negative case control, vaccine effectiveness
Sažetak
Introduction Influenza A(H3N2) clades 3C.2a and 3C.3a co-circulated in Europe in 2018/19. Immunological imprinting by first childhood influenza infection may induce future birth cohort differences in vaccine effectiveness (VE). Aim The I-MOVE multicentre primary care test-negative study assessed 2018/19 influenza A(H3N2) VE by age and genetic subgroups to explore VE by birth cohort. Methods We measured VE against influenza A(H3N2) and (sub)clades. We stratified VE by usual age groups (0–14, 15–64, ≥ 65-years). To assess the imprint-regulated effect of vaccine (I-REV) hypothesis, we further stratified the middle-aged group, notably including 32–54-year-olds (1964–86) sharing potential childhood imprinting to serine at haemagglutinin position 159. Results Influenza A(H3N2) VE among all ages was −1% (95% confidence interval (CI): −24 to 18) and 46% (95% CI: 8–68), −26% (95% CI: −66 to 4) and 20% (95% CI: −20 to 46) among 0–14, 15–64 and ≥ 65-year-olds, respectively. Among 15–64-year-olds, VE against clades 3C.2a1b and 3C.3a was 15% (95% CI: −34 to 50) and −74% (95% CI: −259 to 16), respectively. VE was −18% (95% CI: −140 to 41), −53% (95% CI: −131 to −2) and −12% (95% CI: −74 to 28) among 15–31-year-olds (1987–2003), 32–54-year-olds (1964–86) and 55–64-year-olds (1954–63), respectively. Discussion The lowest 2018/19 influenza A(H3N2) VE was against clade 3C.3a and among those born 1964–86, corresponding to the I-REV hypothesis. The low influenza A(H3N2) VE in 15–64-year-olds and the public health impact of the I-REV hypothesis warrant further study.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE